Home
Scholarly Works
Reply to the letter regarding the article...
Journal article

Reply to the letter regarding the article ‘Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial’

Authors

Branch KRH; Gerstein HC; Probstfield JL

Journal

European Journal of Heart Failure, Vol. 24, No. 11, pp. 2207–2208

Publisher

Oxford University Press (OUP)

Publication Date

November 1, 2022

DOI

10.1002/ejhf.2719

ISSN

1388-9842

Contact the Experts team